Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness

DI Velligan, M Sajatovic, A Hatch… - Patient preference …, 2017 - Taylor & Francis
Background Antipsychotic medication reduces the severity of serious mental illness (SMI)
and improves patient outcomes only when medicines were taken as prescribed …

Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review

S García, M Martínez-Cengotitabengoa… - Journal of clinical …, 2016 - journals.lww.com
Antipsychotics are the drugs prescribed to treat psychotic disorders; however, patients often
fail to adhere to their treatment, and this has a severe negative effect on prognosis in these …

Nonadherence to medication therapy in haemodialysis patients: a systematic review

S Ghimire, RL Castelino, NM Lioufas, GM Peterson… - PloS one, 2015 - journals.plos.org
Background End-stage kidney disease (ESKD) patients are often prescribed multiple
medications. Together with a demanding weekly schedule of dialysis sessions, increased …

Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: a systematic review and meta-analysis

E Loots, E Goossens, T Vanwesemael… - International Journal of …, 2021 - mdpi.com
Adherence to prescribed medication regimes improves outcomes for patients with severe
mental illness such as schizophrenia or bipolar disorders. The aim of this systematic review …

Does relapse contribute to treatment resistance? Antipsychotic response in first-vs. second-episode schizophrenia

H Takeuchi, C Siu, G Remington, G Fervaha… - …, 2019 - nature.com
Although some studies have suggested that relapse may be associated with antipsychotic
treatment resistance in schizophrenia, the number and quality of studies is limited. The …

The role of shared decision-making in improving adherence to pharmacological treatments in patients with schizophrenia: a clinical review

A Fiorillo, S Barlati, A Bellomo, G Corrivetti… - Annals of General …, 2020 - Springer
Shared decision-making (SDM) is a process in which the doctor provides clear and
complete medical information to patients about their treatment, and patients provide …

Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology

TRE Barnes, R Drake, C Paton… - Journal of …, 2020 - journals.sagepub.com
These updated guidelines from the British Association for Psychopharmacology replace the
original version published in 2011. They address the scope and targets of pharmacological …

Antipsychotic treatment failure: a systematic review on risk factors and interventions for treatment adherence in psychosis

K El Abdellati, L De Picker, M Morrens - Frontiers in neuroscience, 2020 - frontiersin.org
Objective: Antipsychotic medication non-adherence has detrimental effects on patients'
clinical outcome. It is unclear which risk factors affect adherence most and which …

Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European …

D Novick, W Montgomery, T Treuer, J Aguado… - BMC psychiatry, 2015 - Springer
Background Many patients with schizophrenia and bipolar disorder have impaired insight
and low medication adherence. The aim of this post hoc analysis was to explore the …

Adherence to oral antipsychotics measured by electronic adherence monitoring in schizophrenia: a systematic review and meta-analysis

H Yaegashi, S Kirino, G Remington, F Misawa… - CNS drugs, 2020 - Springer
Background Poor adherence to oral antipsychotics is common in patients with
schizophrenia; nonetheless, there has been no systematic review or meta-analysis on …